Skip to content
Open access

Features of the clinical course and approaches to the treatment of idiopathic inflammatory myopathies: analysis of clinical observations

Oct 2026 · Yakut Medical Journal · 0 citations · 12 references

TL;DR

A retrospective analysis was conducted on data from 23 patients with IVM hospitalized at the National Center for Maternal and Child Health of the Ministry of Health of the Kyrgyz Republic between 2022 and 2025, finding that the incidence rate increased 2.5-fold compared to the 2015–2022 period.

Abstract

Idiopathic inflammatory myopathies (IIM) are rare pediatric rheumatic diseases characterized by delayed diagnosis and a variable clinical course. The aim of the study is to evaluate the clinical course characteristics and therapeutic approaches regarding IVM in the Kyrgyz Republic. A retrospective analysis was conducted on data from 23 patients with IVM hospitalized at the National Center for Maternal and Child Health of the Ministry of Health of the Kyrgyz Republic between 2022 and 2025. Juvenile dermatomyositis predominated (91.3%), with disease onset at a median age of 7.5 (4.5; 9.0) years. The most common manifestations were myopathic syndrome, heliotrope rash, and involvement of the lungs and gastrointestinal tract. The incidence rate increased 2.5-fold compared to the 2015–2022 period. The therapy included systemic glucocorticosteroids, methotrexate, intravenous immunoglobulin, and—in resistant cases—genetically engineered biological agents. Remission was achieved in all patients within the first year of treatment, though without complete discontinuation of glucocorticosteroids.

Read PDF

Similar papers

Open access Sep 2026

29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY

Background. Genodermatoses are a group of rare inherited disorders affecting the skin and its adnexa. Their clinical presentation is heterogeneous, reflecting the wide underlying genetic heterogeneity. The manifestations have a strong impact on the quality of life and on the duration. To date, there are no therapeutic...

Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica · 0 citations
Sep 2026

Relapse in adult idiopathic inflammatory myopathies: clinical predictors and the potential role of anti-NXP2 in a single-center retrospective cohort study.

Younger age, anti-NXP2 positivity, and IVIG use independently increased relapse risk, whereas long-term maintenance therapy substantially delayed relapse, highlighting the need for long-term immunosuppression and close monitoring of high-risk subgroups.

M. Ekici, İ. Y. İçli, G. Yardımcı et al. · 0 citations
Open access Sep 2026

Juvenile Idiopathic Arthritis in Chad: Delayed Diagnosis, Clinical Patterns and Limited Access to Biologics

Background: Juvenile idiopathic arthritis (JIA) is the leading cause of chronic inflammatory rheumatism in children, yet data from Central Africa remain scarce. This study aimed to describe the clinical patterns, diagnostic delay and access to biologic therapies in children with JIA in Chad. Methods: Retrospective stu...

Garba Harine Abdel Aziz, A. Bah, R. Bouchrane et al. · 0 citations
Review Open access Sep 2026

Clinical Outcomes and Treatment Efficacy in Juvenile Myasthenia Gravis: A Retrospective Review From a Single Center

Early recognition and treatment are critical in juvenile myasthenia gravis (JMG), yet pediatric‐specific evidence remains limited. We aimed to describe treatment patterns, remission rates, and predictors in a Canadian cohort.

Tanitnun Paprad, E. Nigro, Z. Aleisa et al. · 0 citations
Oct 2026

[Clinical characteristics of primary Sjögren syndrome with leukopenia].

The clinical characteristics of leukopenia are analyzed in a large cohort of patients with primary Sjögren syndrome to discuss its pathogenic mechanism, and to enhance clinicians ' understanding of the disease, and reduce missed diagnosis and misdiagnosis.

Zhen-Hang Zhu, Fang Cheng, Yan-Ling Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.